Atlas Trials

Childhood Mixed Phenotype Acute Leukemia

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Childhood Mixed Phenotype Acute Leukemia

RecordFirmDate
A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia (NCT07498465)Children's Oncology Group2026-09-10

Track Childhood Mixed Phenotype Acute Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.